Plain-English translation of NCT06402695 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This is an observational study โ meaning researchers will gather and analyze your medical records, test results, and tumor samples rather than ask you to take a new medication. The study aims to better understand neuroendocrine tumors (rare tumors that grow from hormone-producing cells in the digestive system or lungs) and find new ways to predict which treatments will work best for each patient.
Currently, doctors use standard classification systems and staging to guide treatment decisions, but these don't fully explain why some patients respond well to therapy while others don't. This study seeks to discover new biological markers and patterns in tumor tissue that could help doctors personalize treatment plans and predict outcomes more accurately.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join, researchers will review your existing medical records, imaging results, and tumor tissue samples collected during your normal cancer care โ you will not need to undergo additional procedures solely for this study. The study has two parts: a review of past patient records (going back to 2010) and ongoing collection of information from new patients over the next three years. Your participation involves allowing the research team to analyze your data to help improve understanding of how to treat these tumors better.
AI-generated summary from trial data ยท Jun 12, 2026 ยท Not medical advice
Italy
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Enrollment target
~650 participants
Started
September 2023
Primary completion
December 2025
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in May 2024.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Maria Grazia Maratta, MD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.